We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science
At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.
Health Canada’s Good Manufacturing Practices Guide for Drug Products (GUI-0001) is essential for pharmaceutical companies operating in or exporting to
In generic drug development, the biggest delays rarely come from what sponsors do not know. They come from what
In pharmaceutical development, the acronyms GMP, GCP, and GLP represent the “Golden Trio” of quality standards, ensuring that every drug
In pharmaceutical development, the pharmacokinetic (PK) statistical review serves as a crucial link between biological data and regulatory acceptance, establishing
India is a significant player in the global pharmaceuticals sector, characterized by a diverse population and cost-effective infrastructure. However, its
The FDA issued 466 Form 483s to drug organizations in FY 2022, more than double the previous year, highlighting significant
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.
